Successful Deals with PwC: KARL STORZ acquires Anklin

The Corporate Finance/M&A team is pleased to announce the sale of Anklin AG (“Anklin”) to KARL STORZ SE & Co. KG (“KARL STORZ”). PwC supported Anklin as lead financial advisor.

The transaction brings KARL STORZ closer to its customers and their individual needs regarding products and services and is in line with its strategy to further expand direct sales, while it allows the Anklin family to secure their succession and transfer the highly successful company to a new owner.

Founded in 1954 and headquartered in Reinach BL, Switzerland, Anklin is a distributor of high-precision medical instruments and devices in the field of endoscopy for human and veterinary medicine. Known for its exceptional service quality, Anklin has established itself as a very well-known brand in Switzerland. With a successful history of collaboration with KARL STORZ, Anklin has continually advanced its offerings to meet the evolving needs of the medical endoscopes industry. The company serves the entire Swiss market in all language regions and employs a dedicated team of around 70 specialists.

Founded in 1945 in Tuttlingen, Germany, KARL STORZ is a global leader in endoscopy and medical instruments. The family-owned company, now in its third generation, employs 9’400 people across more than 40 countries. KARL STORZ offers a diverse portfolio of 13’000 products for both human and veterinary medicine. In 2023, the company reported sales of 2.17 billion euros. KARL STORZ operates production sites in Germany, the USA, Switzerland, and Estonia.

PwC Corporate Finance/M&A is proud to have advised the Anklin family shareholders as lead financial advisor on their journey towards this successful deal. In addition to the sale of Anklin's KARL STORZ-related business to its key supplier, KARL STORZ, the deal also required the carve-out of Anklin's additional business not related to KARL STORZ and its subsequent sale to Asker Healthcare Group and Burkart Medizintechnik GmbH in two separate additional asset deals.